Biologics Contract Development And Manufacturing (CDMO) Is The Fastest Growing Segment Fueling Growth Of The Biopharmaceutical CMO And CRO Market


https://www.coherentmarketinsights.com/market-insight/biopharmaceutical-cmo-and-cro-market-5933
Biopharmaceutical CMO And CRO Market


Market Overview:

The biopharmaceutical CMO and CRO market comprises companies that offer services related to development and manufacturing of biopharmaceutical drugs on a contract basis. They provide end-to-end services from drug development to commercial manufacturing. Their expertise helps small and large biotech companies focus on core activities.

Market key trends:
One of the key trends driving growth in the biopharmaceutical CMO and CRO market is the increasing adoption of biologics over traditional small molecule drugs. Biologics have revolutionized treatment for various diseases but their development and manufacturing is highly complex and specialized. This has led more biotech companies to rely on CDMOs and CROs having expertise in bioprocessing and analytical services. Another major trend is the shift towards single-use technologies by CDMOs to offer flexible, rapid and cost-effective manufacturing solutions to clients. This is helping biotech innovators speed up development and launch of biologics.
Segment Analysis

The biopharmaceutical contract manufacturing and contract research organizations (CMO and CRO) market is segmented based on services, therapeutic area, and scale of operation. Within services, contract development and manufacturing organization (CDMO) services dominate the market. CDMOs offer end-to-end services from product development to commercial manufacturing, which is driving their high adoption among biopharmaceutical companies to focus on their core areas.

The global Biopharmaceutical CMO and CRO Market Demand is estimated to be valued at US$ 36.2 Bn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Key Takeaways

The global Biopharmaceutical CMO and CRO Market is expected to witness high growth, exhibiting CAGR of 5.9% over the forecast period, due to increasing R&D investments by pharmaceutical companies in cell and gene therapies.


North America is expected to dominate the global biopharmaceutical CMO and CRO market over the forecast period. This is attributed to presence of majority of global players and growing biologics market in the region. Asia Pacific region is expected to exhibit highest growth rate owing to low-cost operations and increasing foreign investments in countries like China and India.


Key players operating in the Biopharmaceutical CMO and CRO market are Allphase Clinical Research, AlcheraBio, Alcami, Akos Urgent Care, Agilent, AGC Biologics, Affinity Life Sciences, Inc., Actimus Bio, ACI Clinical, Accumedix, Inc., Absorption Systems, A10 Clinical Solutions, Albuquerque Clinical Trials (ACT), Ajinomoto Bio-Pharma Services, Advanced Clinical Services LLC, ACM Global Laboratories, Accelerated Enrollment Solutions, AbbVie Contract Manufacturing, Advanced BioScience Laboratories, Advanced Clinical Research Institute, and Alliance for Clinical Trials in Oncology, among others

Comments

Post a Comment

Popular posts from this blog

Agricultural Micronutrients Market Growth Accelerated By Increasing Need For Improved Soil Fertility

Image
Agricultural Micronutrients Market Agricultural micronutrients are essential plant nutrients required in small quantities for healthy plant growth and development. Micronutrients such as iron, zinc, manganese, molybdenum, and boron play vital roles in various metabolic functions of crops such as photosynthesis, nitrogen fixation, and enzyme activity. The increasing need to boost crop yields and improve soil fertility has raised the demand for micronutrient fertilizers globally. The growing population and reducing arable land have fueled the need for sustainable agricultural practices, propelling the micronutrients market. The global Agricultural Micronutrients Market is estimated to be valued at US$ 5.19 Bn in 2024 and is expected to exhibit a CAGR of 27.% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: The increasing adoption of precision farming and digital technologies in the agriculture sector is
Read more

Dairy Alternative Market Expected To Reach USD 26.01 Billion By 2023

Image
Dairy Alternative Market Market Overview: Dairy alternative products are gaining significant popularity due to their numerous advantages. These products are plant-based, making them suitable for individuals with lactose intolerance or those following a vegan diet. They offer similar nutritional benefits as traditional dairy products such as milk, cheese, and yogurt, while also addressing concerns related to animal welfare and environmental sustainability. The growing demand for dairy alternative products among health-conscious consumers is driving market growth. Market Key Trends: One key trend observed in the dairy alternative market is the increasing preference for plant-based milk substitutes. Plant-based milk alternatives such as almond milk, soy milk, and oat milk, among others, are gaining traction among consumers as a healthier and more sustainable option compared to traditional dairy milk. These plant-based milk alternatives offer various benefits such as being lactose-free, c
Read more

Antimicrobial Additives Market Growth Accelerated By Rising Demand From End-Use Industries

Image
Antimicrobial Additives Market Antimicrobial additives are extensively used in a wide range of end-use industries such as healthcare, packaging, food and beverage, construction, and automotive. These additives help protect various materials from microorganisms such as bacteria, viruses, etc. Some key applications of antimicrobial additives include packaging of food, medical devices, fabrics, flooring, coatings, etc. The ongoing COVID-19 pandemic has further increased the importance of hygiene and sanitation, driving demand for antimicrobial materials from various sectors. The global Antimicrobial Additives Market is estimated to be valued at US$ 3.47 Bn in 2024 and is expected to exhibit a CAGR of 25.% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: One of the key drivers of the market's growth is the rising demand for antimicrobial additives from the packaging industry. Packaging manufacturers
Read more